Characteristics | HIPEC Group (n = 40) | Control group (n = 40) | P value |
---|---|---|---|
Sex (n, %) | |||
 Male | 23 (57.5) | 23 (57.5) | 1 |
 Female | 17 (42.5) | 17 (42.5) | |
 Mean age (years, range) | 59 ± 10 (23–72) | 58 ± 10 (36–74) | 0.95 |
 Mean KPS score (range) | 85 ± 6 (70–90) | 85 ± 6 (70–90) | 0.979 |
Histopathology (n, %) | |||
 Adenocarcinoma (poor or moderately differentiated) (n, %) | 25 (62.5) | 26 (65) | 1 |
 Adenocarcinoma (Mucinous, signet cell or other type) (n, %) | 15 {37.5) | 14 (35) | |
Pre-operative Blood physiological and biochemical Parameters | |||
 WBC (109/L) | 5.7 ± 1.4 | 5.7 ± 1.4 | 0.785 |
 RBC (1012/L) | 4.2 ± 0.6 | 4.3 ± 0.5 | 0.78 |
 Hb (g/L) | 130 ± 14 | 127 ± 20 | 0.339 |
 Alb (g/L) | 40 ± 5 | 39 ± 4 | 0.152 |
 AST (IU/L) | 20.4 ± 6.3 | 19.4 ± 8.1 | 0.094 |
 ALT (IU/L) | 20.3 ± 9.3 | 17.1 ± 8.2 | 0.854 |
 TB (umol/L) | 13.2 ± 4.6 | 12.9 ± 3.9 | 0.456 |
 DB (umol/L) | 2.2 ± 1.0 | 2.3 ± 0.08 | 0.626 |
 SCr (umol/L) | 73.5 ± 15.2 | 76.8 ± 27.3 | 0.134 |
 K+ (mmol/L) | 3.95 ± 0.45 | 3.84 ± 0.39 | 0.456 |
 Na+ (mmol/L) | 141 ± 5 | 140 ± 4 | 0.334 |